Wolverine Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
3,000
-7,900
-72% -$2.82M 0.01% 760
2025
Q4
$3.57M Sell
10,900
-800
-7% -$254K 0.03% 434
2025
Q3
$3.3M Sell
11,700
-2,900
-20% -$841K 0.02% 447
2025
Q2
$4.08M Sell
14,600
-5,500
-27% -$1.56M 0.04% 379
2025
Q1
$6.26M Sell
20,100
-11,300
-36% -$3.34M 0.07% 263
2024
Q4
$8.18M Sell
31,400
-24,100
-43% -$7.15M 0.08% 231
2024
Q3
$17.9M Sell
55,500
-29,400
-35% -$9.62M 0.19% 131
2024
Q2
$26.5M Buy
84,900
+20,600
+32% +$6.05M 0.3% 89
2024
Q1
$18.3M Buy
64,300
+20,000
+45% +$5.85M 0.21% 119
2023
Q4
$12.8M Buy
44,300
+1,500
+4% +$409K 0.11% 198
2023
Q3
$11.5M Sell
42,800
-19,400
-31% -$4.84M 0.13% 181
2023
Q2
$13.8M Sell
62,200
-4,500
-7% -$1.04M 0.16% 143
2023
Q1
$16.1M Buy
66,700
+63,700
+2,123% +$15.6M 0.19% 139
2022
Q4
$788K Buy
+3,000
New +$804K 0.01% 808
2017
Q1
Sell
-700
Closed -$102K 1172
2016
Q4
$102K Sell
700
-300
-30% -$45.1K ﹤0.01% 934
2016
Q3
$166K Hold
1,000
﹤0.01% 902
2016
Q2
$152K Buy
1,000
+990
+9,900% +$154K ﹤0.01% 921
2016
Q1
$41K Sell
10
-20
-67% -$2.97K ﹤0.01% 891
2015
Q4
$35K Hold
30
﹤0.01% 1210
2015
Q3
$58K Sell
30
-5
-14% -$788 ﹤0.01% 1234
2015
Q2
$55K Sell
35
-10
-22% -$1.6K ﹤0.01% 1277
2015
Q1
$35K Buy
+45
New +$7.09K ﹤0.01% 1332
2014
Q4
Sell
-413
Closed -$40K 2135
2014
Q3
$40K Buy
+413
New +$53.9K ﹤0.01% 1600
2014
Q1
Sell
-945
Closed -$267K 2372
2013
Q4
$267K Sell
945
-25
-3% -$2.84K 0.01% 1036
2013
Q3
$373K Sell
970
-166
-15% -$18K 0.01% 884
2013
Q2
$759K Buy
+1,136
New +$118K 0.02% 569

Other funds holding AMGN

Wolverine Asset Management's AMGN Position: Q4 2025 in Review

Wolverine Asset Management sold out of Amgen (AMGN) in Q4 2025, closing a stake of 3,141 shares — an estimated $996K sold.

Wolverine Asset Management first reported a position in AMGN in Q2 2013 and held it in 24 quarters. The position peaked at $58.9M in Q4 2017. 3,084 funds tracked by Wall St. Rank hold AMGN as of Q4 2025.

  • Wolverine Asset Management reported no remaining Amgen position as of Q4 2025 after selling out during the quarter.
  • Wolverine Asset Management sold 3,141 Amgen shares in Q4 2025, an estimated $996K.
  • Wolverine Asset Management first reported a position in Amgen in Q2 2013 and held it in 24 quarters.
  • Wolverine Asset Management's Amgen position peaked at $58.9M in Q4 2017.
  • 3,084 funds tracked by Wall St. Rank held Amgen as of Q4 2025.

Based on Wolverine Asset Management's 13F filing for Q4 2025, filed 2 Feb 2026.